JP6899590B2 - 膜型カテーテル - Google Patents

膜型カテーテル Download PDF

Info

Publication number: JP6899590B2
Authority: JP; Japan
Prior art keywords: catheter; blood; membrane; substance; hollow fiber
Prior art date: 2015-10-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Fee Related

Application number

JP2018519428A

Other languages

English (en)

Japanese (ja)

Other versions

JP2018535731A5 (2

JP2018535731A (ja

Inventor

スザンナノイドゥル

ローマンウルリッヒ

クラウス−ゲオルククレン

クリストフジャネチェック

マーギットグフォーラー

Original Assignee

シーコアテクノロジーゲーエムベーハー

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2015-10-14

Filing date

2016-10-14

Publication date

2021-07-07

2016-10-14 Application filed by シーコアテクノロジーゲーエムベーハー, シーコアテクノロジーゲーエムベーハー filed Critical シーコアテクノロジーゲーエムベーハー

2018-12-06 Publication of JP2018535731A publication Critical patent/JP2018535731A/ja

2020-02-27 Publication of JP2018535731A5 publication Critical patent/JP2018535731A5/ja

2021-07-07 Application granted granted Critical

2021-07-07 Publication of JP6899590B2 publication Critical patent/JP6899590B2/ja

Status Expired - Fee Related legal-status Critical Current

2036-10-14 Anticipated expiration legal-status Critical

Links

239000012528 membrane Substances 0.000 title claims description 185
239000008280 blood Substances 0.000 claims description 150
210000004369 blood Anatomy 0.000 claims description 150
239000000126 substance Substances 0.000 claims description 81
230000008878 coupling Effects 0.000 claims description 80
238000010168 coupling process Methods 0.000 claims description 80
238000005859 coupling reaction Methods 0.000 claims description 80
239000007788 liquid Substances 0.000 claims description 60
239000000463 material Substances 0.000 claims description 35
230000005291 magnetic effect Effects 0.000 claims description 34
239000012530 fluid Substances 0.000 claims description 28
230000017531 blood circulation Effects 0.000 claims description 26
238000000034 method Methods 0.000 claims description 21
OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 19
239000000243 solution Substances 0.000 claims description 19
108010088751 Albumins Proteins 0.000 claims description 18
102000009027 Albumins Human genes 0.000 claims description 18
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 18
201000010099 disease Diseases 0.000 claims description 17
102000004169 proteins and genes Human genes 0.000 claims description 13
108090000623 proteins and genes Proteins 0.000 claims description 13
230000004087 circulation Effects 0.000 claims description 12
TXEYQDLBPFQVAA-UHFFFAOYSA-N tetrafluoromethane Chemical compound FC(F)(F)F TXEYQDLBPFQVAA-UHFFFAOYSA-N 0.000 claims description 12
238000012546 transfer Methods 0.000 claims description 11
238000000926 separation method Methods 0.000 claims description 10
239000003463 adsorbent Substances 0.000 claims description 9
230000005294 ferromagnetic effect Effects 0.000 claims description 8
210000004204 blood vessel Anatomy 0.000 claims description 7
230000005292 diamagnetic effect Effects 0.000 claims description 6
239000008151 electrolyte solution Substances 0.000 claims description 6
150000002303 glucose derivatives Chemical class 0.000 claims description 5
241001465754 Metazoa Species 0.000 claims description 4
244000052769 pathogen Species 0.000 claims description 3
231100000331 toxic Toxicity 0.000 claims description 3
230000002588 toxic effect Effects 0.000 claims description 3
230000001717 pathogenic effect Effects 0.000 claims description 2
239000011259 mixed solution Substances 0.000 claims 1
239000012510 hollow fiber Substances 0.000 description 134
230000032258 transport Effects 0.000 description 31
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 20
239000007789 gas Substances 0.000 description 20
239000003053 toxin Substances 0.000 description 20
231100000765 toxin Toxicity 0.000 description 20
108700012359 toxins Proteins 0.000 description 20
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 19
239000001301 oxygen Substances 0.000 description 19
229910052760 oxygen Inorganic materials 0.000 description 19
239000002088 nanocapsule Substances 0.000 description 18
238000013461 design Methods 0.000 description 17
210000004072 lung Anatomy 0.000 description 16
239000000835 fiber Substances 0.000 description 13
239000003094 microcapsule Substances 0.000 description 13
230000008901 benefit Effects 0.000 description 10
239000001569 carbon dioxide Substances 0.000 description 10
229910002092 carbon dioxide Inorganic materials 0.000 description 10
230000006870 function Effects 0.000 description 9
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 8
239000000306 component Substances 0.000 description 8
239000008103 glucose Substances 0.000 description 8
210000003462 vein Anatomy 0.000 description 8
238000000502 dialysis Methods 0.000 description 7
239000002775 capsule Substances 0.000 description 6
239000003792 electrolyte Substances 0.000 description 6
150000002500 ions Chemical class 0.000 description 6
239000000203 mixture Substances 0.000 description 6
-1 polyethylene Polymers 0.000 description 6
238000011282 treatment Methods 0.000 description 6
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 5
238000009792 diffusion process Methods 0.000 description 5
229940021013 electrolyte solution Drugs 0.000 description 5
239000000839 emulsion Substances 0.000 description 5
239000003822 epoxy resin Substances 0.000 description 5
238000006213 oxygenation reaction Methods 0.000 description 5
239000012466 permeate Substances 0.000 description 5
229920000647 polyepoxide Polymers 0.000 description 5
229920000642 polymer Polymers 0.000 description 5
229910052710 silicon Inorganic materials 0.000 description 5
239000010703 silicon Substances 0.000 description 5
206010001526 Air embolism Diseases 0.000 description 4
239000004952 Polyamide Substances 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
230000027455 binding Effects 0.000 description 4
239000000084 colloidal system Substances 0.000 description 4
239000010408 film Substances 0.000 description 4
230000004199 lung function Effects 0.000 description 4
238000004519 manufacturing process Methods 0.000 description 4
229920002647 polyamide Polymers 0.000 description 4
229920001296 polysiloxane Polymers 0.000 description 4
229920002635 polyurethane Polymers 0.000 description 4
239000004814 polyurethane Substances 0.000 description 4
229920000036 polyvinylpyrrolidone Polymers 0.000 description 4
239000001267 polyvinylpyrrolidone Substances 0.000 description 4
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 4
230000000241 respiratory effect Effects 0.000 description 4
229920001651 Cyanoacrylate Polymers 0.000 description 3
208000007536 Thrombosis Diseases 0.000 description 3
239000006096 absorbing agent Substances 0.000 description 3
125000000129 anionic group Chemical group 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
230000036770 blood supply Effects 0.000 description 3
230000008859 change Effects 0.000 description 3
238000001784 detoxification Methods 0.000 description 3
230000000694 effects Effects 0.000 description 3
238000002618 extracorporeal membrane oxygenation Methods 0.000 description 3
239000003302 ferromagnetic material Substances 0.000 description 3
239000011888 foil Substances 0.000 description 3
150000002632 lipids Chemical class 0.000 description 3
229920002492 poly(sulfone) Polymers 0.000 description 3
239000011116 polymethylpentene Substances 0.000 description 3
239000011780 sodium chloride Substances 0.000 description 3
238000000108 ultra-filtration Methods 0.000 description 3
229920002284 Cellulose triacetate Polymers 0.000 description 2
102000004127 Cytokines Human genes 0.000 description 2
108090000695 Cytokines Proteins 0.000 description 2
229920000219 Ethylene vinyl alcohol Polymers 0.000 description 2
239000004698 Polyethylene Substances 0.000 description 2
239000004743 Polypropylene Substances 0.000 description 2
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
239000004433 Thermoplastic polyurethane Substances 0.000 description 2
NNLVGZFZQQXQNW-ADJNRHBOSA-N [(2r,3r,4s,5r,6s)-4,5-diacetyloxy-3-[(2s,3r,4s,5r,6r)-3,4,5-triacetyloxy-6-(acetyloxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6s)-4,5,6-triacetyloxy-2-(acetyloxymethyl)oxan-3-yl]oxyoxan-2-yl]methyl acetate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](OC(C)=O)[C@H]1OC(C)=O)O[C@H]1[C@@H]([C@@H](OC(C)=O)[C@H](OC(C)=O)[C@@H](COC(C)=O)O1)OC(C)=O)COC(=O)C)[C@@H]1[C@@H](COC(C)=O)O[C@@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1OC(C)=O NNLVGZFZQQXQNW-ADJNRHBOSA-N 0.000 description 2
230000023555 blood coagulation Effects 0.000 description 2
230000036772 blood pressure Effects 0.000 description 2
230000036760 body temperature Effects 0.000 description 2
239000012876 carrier material Substances 0.000 description 2
238000004891 communication Methods 0.000 description 2
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
230000006378 damage Effects 0.000 description 2
238000002405 diagnostic procedure Methods 0.000 description 2
239000013013 elastic material Substances 0.000 description 2
230000002357 endometrial effect Effects 0.000 description 2
239000002158 endotoxin Substances 0.000 description 2
238000005516 engineering process Methods 0.000 description 2
230000004217 heart function Effects 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
230000007774 longterm Effects 0.000 description 2
230000005415 magnetization Effects 0.000 description 2
238000005259 measurement Methods 0.000 description 2
238000005399 mechanical ventilation Methods 0.000 description 2
230000007246 mechanism Effects 0.000 description 2
238000001690 micro-dialysis Methods 0.000 description 2
230000004048 modification Effects 0.000 description 2
238000012986 modification Methods 0.000 description 2
230000035515 penetration Effects 0.000 description 2
230000010412 perfusion Effects 0.000 description 2
230000035699 permeability Effects 0.000 description 2
229920003229 poly(methyl methacrylate) Polymers 0.000 description 2
229920000573 polyethylene Polymers 0.000 description 2
239000004926 polymethyl methacrylate Substances 0.000 description 2
229920000306 polymethylpentene Polymers 0.000 description 2
229920001155 polypropylene Polymers 0.000 description 2
BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
238000010992 reflux Methods 0.000 description 2
239000000932 sedative agent Substances 0.000 description 2
230000009870 specific binding Effects 0.000 description 2
230000002269 spontaneous effect Effects 0.000 description 2
239000000758 substrate Substances 0.000 description 2
239000013076 target substance Substances 0.000 description 2
238000002560 therapeutic procedure Methods 0.000 description 2
229920002803 thermoplastic polyurethane Polymers 0.000 description 2
210000001631 vena cava inferior Anatomy 0.000 description 2
210000002620 vena cava superior Anatomy 0.000 description 2
238000009423 ventilation Methods 0.000 description 2
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
206010001605 Alcohol poisoning Diseases 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102000003846 Carbonic anhydrases Human genes 0.000 description 1
108090000209 Carbonic anhydrases Proteins 0.000 description 1
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
208000032928 Dyslipidaemia Diseases 0.000 description 1
108090000790 Enzymes Proteins 0.000 description 1
102000004190 Enzymes Human genes 0.000 description 1
102000051325 Glucagon Human genes 0.000 description 1
108060003199 Glucagon Proteins 0.000 description 1
102000001554 Hemoglobins Human genes 0.000 description 1
108010054147 Hemoglobins Proteins 0.000 description 1
208000032843 Hemorrhage Diseases 0.000 description 1
HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
208000002682 Hyperkalemia Diseases 0.000 description 1
206010021143 Hypoxia Diseases 0.000 description 1
108060003951 Immunoglobulin Proteins 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
238000012695 Interfacial polymerization Methods 0.000 description 1
102000015696 Interleukins Human genes 0.000 description 1
108010063738 Interleukins Proteins 0.000 description 1
208000017170 Lipid metabolism disease Diseases 0.000 description 1
206010027439 Metal poisoning Diseases 0.000 description 1
MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 1
239000000020 Nitrocellulose Substances 0.000 description 1
229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
239000004695 Polyether sulfone Substances 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
206010068733 Respiratory fatigue Diseases 0.000 description 1
XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
208000027418 Wounds and injury Diseases 0.000 description 1
PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
238000009825 accumulation Methods 0.000 description 1
230000009471 action Effects 0.000 description 1
230000001154 acute effect Effects 0.000 description 1
230000000274 adsorptive effect Effects 0.000 description 1
WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
208000034158 bleeding Diseases 0.000 description 1
230000000740 bleeding effect Effects 0.000 description 1
239000012503 blood component Substances 0.000 description 1
239000003633 blood substitute Substances 0.000 description 1
230000037396 body weight Effects 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
239000004202 carbamide Substances 0.000 description 1
229910052799 carbon Inorganic materials 0.000 description 1
239000000969 carrier Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
230000000295 complement effect Effects 0.000 description 1
239000012141 concentrate Substances 0.000 description 1
229920001577 copolymer Polymers 0.000 description 1
229910052802 copper Inorganic materials 0.000 description 1
239000010949 copper Substances 0.000 description 1
229940109239 creatinine Drugs 0.000 description 1
NLCKLZIHJQEMCU-UHFFFAOYSA-N cyano prop-2-enoate Chemical class C=CC(=O)OC#N NLCKLZIHJQEMCU-UHFFFAOYSA-N 0.000 description 1
230000007547 defect Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
239000000385 dialysis solution Substances 0.000 description 1
238000007599 discharging Methods 0.000 description 1
208000035475 disorder Diseases 0.000 description 1
238000004090 dissolution Methods 0.000 description 1
238000009826 distribution Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
JJJFUHOGVZWXNQ-UHFFFAOYSA-N enbucrilate Chemical compound CCCCOC(=O)C(=C)C#N JJJFUHOGVZWXNQ-UHFFFAOYSA-N 0.000 description 1
229950010048 enbucrilate Drugs 0.000 description 1
230000002255 enzymatic effect Effects 0.000 description 1
RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
239000004715 ethylene vinyl alcohol Substances 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
210000003722 extracellular fluid Anatomy 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
239000007850 fluorescent dye Substances 0.000 description 1
238000011010 flushing procedure Methods 0.000 description 1
239000006260 foam Substances 0.000 description 1
MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 description 1
229960004666 glucagon Drugs 0.000 description 1
208000007345 glycogen storage disease Diseases 0.000 description 1
238000001631 haemodialysis Methods 0.000 description 1
208000010501 heavy metal poisoning Diseases 0.000 description 1
230000000322 hemodialysis Effects 0.000 description 1
238000002615 hemofiltration Methods 0.000 description 1
229960002897 heparin Drugs 0.000 description 1
229920000669 heparin Polymers 0.000 description 1
229920001477 hydrophilic polymer Polymers 0.000 description 1
102000018358 immunoglobulin Human genes 0.000 description 1
229940072221 immunoglobulins Drugs 0.000 description 1
238000000338 in vitro Methods 0.000 description 1
230000002757 inflammatory effect Effects 0.000 description 1
208000014674 injury Diseases 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
229940047122 interleukins Drugs 0.000 description 1
238000001990 intravenous administration Methods 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
230000003907 kidney function Effects 0.000 description 1
JJTUDXZGHPGLLC-UHFFFAOYSA-N lactide Chemical compound CC1OC(=O)C(C)OC1=O JJTUDXZGHPGLLC-UHFFFAOYSA-N 0.000 description 1
239000007791 liquid phase Substances 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
230000002934 lysing effect Effects 0.000 description 1
ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
239000001095 magnesium carbonate Substances 0.000 description 1
229910000021 magnesium carbonate Inorganic materials 0.000 description 1
239000006249 magnetic particle Substances 0.000 description 1
238000002324 minimally invasive surgery Methods 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000012806 monitoring device Methods 0.000 description 1
VOFUROIFQGPCGE-UHFFFAOYSA-N nile red Chemical compound C1=CC=C2C3=NC4=CC=C(N(CC)CC)C=C4OC3=CC(=O)C2=C1 VOFUROIFQGPCGE-UHFFFAOYSA-N 0.000 description 1
150000002825 nitriles Chemical class 0.000 description 1
229920001220 nitrocellulos Polymers 0.000 description 1
230000003287 optical effect Effects 0.000 description 1
210000000056 organ Anatomy 0.000 description 1
210000000496 pancreas Anatomy 0.000 description 1
239000012071 phase Substances 0.000 description 1
230000004962 physiological condition Effects 0.000 description 1
231100000614 poison Toxicity 0.000 description 1
229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
229920000058 polyacrylate Polymers 0.000 description 1
229920006393 polyether sulfone Polymers 0.000 description 1
239000011148 porous material Substances 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
229910000027 potassium carbonate Inorganic materials 0.000 description 1
230000002265 prevention Effects 0.000 description 1
230000008569 process Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000000746 purification Methods 0.000 description 1
238000012959 renal replacement therapy Methods 0.000 description 1
238000012958 reprocessing Methods 0.000 description 1
229920005989 resin Polymers 0.000 description 1
239000011347 resin Substances 0.000 description 1
229940125723 sedative agent Drugs 0.000 description 1
230000001624 sedative effect Effects 0.000 description 1
150000003384 small molecules Chemical class 0.000 description 1
229910000029 sodium carbonate Inorganic materials 0.000 description 1
238000001179 sorption measurement Methods 0.000 description 1
238000003756 stirring Methods 0.000 description 1
239000004575 stone Substances 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
239000010409 thin film Substances 0.000 description 1
PRZSXZWFJHEZBJ-UHFFFAOYSA-N thymol blue Chemical compound C1=C(O)C(C(C)C)=CC(C2(C3=CC=CC=C3S(=O)(=O)O2)C=2C(=CC(O)=C(C(C)C)C=2)C)=C1C PRZSXZWFJHEZBJ-UHFFFAOYSA-N 0.000 description 1
239000003440 toxic substance Substances 0.000 description 1
239000002441 uremic toxin Substances 0.000 description 1
210000002700 urine Anatomy 0.000 description 1
230000002792 vascular Effects 0.000 description 1
238000010792 warming Methods 0.000 description 1
210000000707 wrist Anatomy 0.000 description 1

Images

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14525—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using microdialysis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1621—Constructional aspects thereof
- A61M1/1623—Disposition or location of membranes relative to fluids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1654—Dialysates therefor
- A61M1/1676—Dialysates therefor containing proteins, e.g. albumin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
- A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
- A61M1/1678—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes intracorporal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/0043—Catheters; Hollow probes characterised by structural features
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/104—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body
- A61M60/109—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body incorporated within extracorporeal blood circuits or systems
- A61M60/113—Extracorporeal pumps, i.e. the blood being pumped outside the patient's body incorporated within extracorporeal blood circuits or systems in other functional devices, e.g. dialysers or heart-lung machines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/10—Location thereof with respect to the patient's body
- A61M60/122—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body
- A61M60/126—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel
- A61M60/13—Implantable pumps or pumping devices, i.e. the blood being pumped inside the patient's body implantable via, into, inside, in line, branching on, or around a blood vessel by means of a catheter allowing explantation, e.g. catheter pumps temporarily introduced via the vascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/20—Type thereof
- A61M60/205—Non-positive displacement blood pumps
- A61M60/216—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller
- A61M60/237—Non-positive displacement blood pumps including a rotating member acting on the blood, e.g. impeller the blood flow through the rotating member having mainly axial components, e.g. axial flow pumps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/30—Medical purposes thereof other than the enhancement of the cardiac output
- A61M60/36—Medical purposes thereof other than the enhancement of the cardiac output for specific blood treatment; for specific therapy
- A61M60/37—Haemodialysis, haemofiltration or diafiltration
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/30—Medical purposes thereof other than the enhancement of the cardiac output
- A61M60/36—Medical purposes thereof other than the enhancement of the cardiac output for specific blood treatment; for specific therapy
- A61M60/38—Blood oxygenation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/403—Details relating to driving for non-positive displacement blood pumps
- A61M60/405—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being hydraulic or pneumatic
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/403—Details relating to driving for non-positive displacement blood pumps
- A61M60/408—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being mechanical, e.g. transmitted by a shaft or cable
- A61M60/411—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being mechanical, e.g. transmitted by a shaft or cable generated by an electromotor
- A61M60/416—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being mechanical, e.g. transmitted by a shaft or cable generated by an electromotor transmitted directly by the motor rotor drive shaft
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/40—Details relating to driving
- A61M60/403—Details relating to driving for non-positive displacement blood pumps
- A61M60/419—Details relating to driving for non-positive displacement blood pumps the force acting on the blood contacting member being permanent magnetic, e.g. from a rotating magnetic coupling between driving and driven magnets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/884—Constructional details other than related to driving of implantable pumps or pumping devices being associated to additional implantable blood treating devices
- A61M60/886—Blood oxygenators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M60/00—Blood pumps; Devices for mechanical circulatory actuation; Balloon pumps for circulatory assistance
- A61M60/80—Constructional details other than related to driving
- A61M60/855—Constructional details other than related to driving of implantable pumps or pumping devices
- A61M60/884—Constructional details other than related to driving of implantable pumps or pumping devices being associated to additional implantable blood treating devices
- A61M60/888—Blood filters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D63/00—Apparatus in general for separation processes using semi-permeable membranes
- B01D63/08—Flat membrane modules
- B01D63/087—Single membrane modules

Landscapes

Health & Medical Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Engineering & Computer Science (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Biomedical Technology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Cardiology (AREA)
Anesthesiology (AREA)
Hematology (AREA)
Mechanical Engineering (AREA)
Urology & Nephrology (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Physics & Mathematics (AREA)
Biophysics (AREA)
Surgery (AREA)
Pathology (AREA)
Medical Informatics (AREA)
Molecular Biology (AREA)
Optics & Photonics (AREA)
Pulmonology (AREA)
Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
External Artificial Organs (AREA)

JP2018519428A 2015-10-14 2016-10-14 膜型カテーテル Expired - Fee Related JP6899590B2 (ja)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
EP15189777.4		2015-10-14
EP15189777		2015-10-14
PCT/EP2016/074776 WO2017064285A1 (de)	2015-10-14	2016-10-14	Membrankatheter

Publications (3)

Publication Number	Publication Date
JP2018535731A JP2018535731A (ja)	2018-12-06
JP2018535731A5 JP2018535731A5 (2)	2020-02-27
JP6899590B2 true JP6899590B2 (ja)	2021-07-07

Family

ID=54325438

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP2018519428A Expired - Fee Related JP6899590B2 (ja)	2015-10-14	2016-10-14	膜型カテーテル

Country Status (13)

Country	Link
US (2)	US10905813B2 (2)
EP (1)	EP3362119B1 (2)
JP (1)	JP6899590B2 (2)
KR (1)	KR20180075550A (2)
CN (1)	CN108472424B (2)
AU (1)	AU2016337004A1 (2)
BR (1)	BR112018007521A2 (2)
CA (1)	CA3000908A1 (2)
ES (1)	ES2797095T3 (2)
MX (1)	MX2018004596A (2)
RU (1)	RU2018117513A (2)
WO (1)	WO2017064285A1 (2)
ZA (1)	ZA201802187B (2)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN106902404B (zh) *	2015-12-23	2019-08-02	丰凯医疗器械（上海）有限公司	经皮辅助泵血装置
EP3634528B1 (en)	2017-06-07	2023-06-07	Shifamed Holdings, LLC	Intravascular fluid movement devices, systems, and methods of use
US11511103B2 (en)	2017-11-13	2022-11-29	Shifamed Holdings, Llc	Intravascular fluid movement devices, systems, and methods of use
DE102018201007B3 (de)	2018-01-23	2019-06-13	Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.	Implantierbares Medizinprodukt
EP3746149B1 (en)	2018-02-01	2025-08-06	Shifamed Holdings, LLC	Intravascular blood pumps
WO2020003110A2 (en) *	2018-06-25	2020-01-02	Modeus Inc.	Percutaneous blood pump and introducer system
WO2020028537A1 (en)	2018-07-31	2020-02-06	Shifamed Holdings, Llc	Intravascaular blood pumps and methods of use
WO2020073047A1 (en)	2018-10-05	2020-04-09	Shifamed Holdings, Llc	Intravascular blood pumps and methods of use
EP3666303A1 (en) *	2018-12-11	2020-06-17	Abiomed Europe GmbH	Catheter for intravascular blood pump
WO2021011473A1 (en)	2019-07-12	2021-01-21	Shifamed Holdings, Llc	Intravascular blood pumps and methods of manufacture and use
US11654275B2 (en)	2019-07-22	2023-05-23	Shifamed Holdings, Llc	Intravascular blood pumps with struts and methods of use and manufacture
US12465748B2 (en)	2019-08-07	2025-11-11	Supira Medical, Inc.	Catheter blood pumps and collapsible pump housings
WO2021062260A1 (en)	2019-09-25	2021-04-01	Shifamed Holdings, Llc	Catheter blood pumps and collapsible blood conduits
US11724089B2 (en)	2019-09-25	2023-08-15	Shifamed Holdings, Llc	Intravascular blood pump systems and methods of use and control thereof
EP4501393A3 (en)	2019-09-25	2025-04-09	Shifamed Holdings, LLC	Catheter blood pumps and collapsible pump housings
DE102019007144A1 (de) *	2019-10-15	2021-04-15	ProMedTec Germany GmbH	Verfahren und Anordnung zur Verbesserung des Austausches von Gasen über semipermeable Membranen im wässrigen Milieu
EP4072650A4 (en)	2019-12-11	2024-01-10	Shifamed Holdings, LLC	Descending aorta and vena cava blood pumps
EP4077947A4 (en)	2019-12-19	2024-01-10	Shifamed Holdings, LLC	INTRAVASCULAR BLOOD PUMPS, MOTORS AND FLUID CONTROL
KR102446541B1 (ko) *	2020-01-31	2022-09-23	한양대학교 산학협력단	카테터 시스템
US20210378678A1 (en) *	2020-06-08	2021-12-09	White Swell Medical Ltd	Non-thrombogenic devices for treating edema
CN113926074B (zh) *	2021-11-04	2023-10-31	丰凯利医疗器械(上海)有限公司	导流传动装置以及血泵系统
CN117379618B (zh) *	2023-11-17	2026-04-28	中国人民解放军陆军军医大学第一附属医院	一种用于血液透析导管的防压器
KR20250105001A (ko)	2023-12-29	2025-07-08	서호영	이산화탄소 분압 측정용 커넥터

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE2737922A1 (de)	1977-08-23	1979-03-08	Fresenius Chem Pharm Ind	Kuenstliche endokrine druese
US4631053A (en) *	1984-03-19	1986-12-23	Taheri Syde A	Oxygenator
JPH04180771A (ja) *	1990-11-16	1992-06-26	Ube Ind Ltd	血液ポンプ一体型人工肺
SE502020C2 (sv) *	1994-02-03	1995-07-17	Gambro Ab	Apparat för peritonealdialys
EP1595555B1 (de) *	2002-07-22	2008-05-28	Novalung GmbH	Intravenöser Oxygenator
US7763097B2 (en) *	2006-06-08	2010-07-27	University of Pittsburgh—of the Commonwealth System of Higher Education	Devices, systems and methods for reducing the concentration of a chemical entity in fluids
WO2008046630A1 (en) *	2006-10-19	2008-04-24	Joanneum Research Forschungsgesellschaft Mbh	Devices for and methods of monitoring a parameter of a fluidic sample by microdialysis
EP2109163A1 (de) *	2008-04-08	2009-10-14	Alcan Technology & Management Ltd.	Substrat mit aufgedruckter Struktur
US9162017B2 (en)	2011-08-29	2015-10-20	Minnetronix, Inc.	Expandable vascular pump
US9446179B2 (en) *	2012-05-14	2016-09-20	Thoratec Corporation	Distal bearing support
EP4186557A1 (en)	2012-07-03	2023-05-31	Tc1 Llc	Motor assembly for catheter pump
US9421311B2 (en) *	2012-07-03	2016-08-23	Thoratec Corporation	Motor assembly for catheter pump
US9308302B2 (en) *	2013-03-15	2016-04-12	Thoratec Corporation	Catheter pump assembly including a stator
AT515555B1 (de) *	2014-05-15	2015-10-15	Univ Wien Tech	Magnetkupplung
US9345824B2 (en) *	2014-07-07	2016-05-24	Assistocor Gmbh & Co Kg	Ventricular assist device
US10709827B2 (en) *	2015-10-14	2020-07-14	Technische Universität Wien	Membrane catheter

2016
- 2016-10-14 BR BR112018007521-3A patent/BR112018007521A2/pt not_active IP Right Cessation
- 2016-10-14 WO PCT/EP2016/074776 patent/WO2017064285A1/de not_active Ceased
- 2016-10-14 US US15/768,705 patent/US10905813B2/en not_active Expired - Fee Related
- 2016-10-14 EP EP16781481.3A patent/EP3362119B1/de active Active
- 2016-10-14 CA CA3000908A patent/CA3000908A1/en not_active Abandoned
- 2016-10-14 CN CN201680071107.2A patent/CN108472424B/zh not_active Expired - Fee Related
- 2016-10-14 RU RU2018117513A patent/RU2018117513A/ru not_active Application Discontinuation
- 2016-10-14 KR KR1020187013572A patent/KR20180075550A/ko not_active Abandoned
- 2016-10-14 AU AU2016337004A patent/AU2016337004A1/en not_active Abandoned
- 2016-10-14 MX MX2018004596A patent/MX2018004596A/es unknown
- 2016-10-14 ES ES16781481T patent/ES2797095T3/es active Active
- 2016-10-14 JP JP2018519428A patent/JP6899590B2/ja not_active Expired - Fee Related
2018
- 2018-04-04 ZA ZA2018/02187A patent/ZA201802187B/en unknown
2021
- 2021-01-15 US US17/150,275 patent/US20210162109A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ES2797095T3 (es)	2020-12-01
CN108472424B (zh)	2021-05-07
US20210162109A1 (en)	2021-06-03
RU2018117513A3 (2)	2020-03-10
JP2018535731A (ja)	2018-12-06
CN108472424A (zh)	2018-08-31
RU2018117513A (ru)	2019-11-14
AU2016337004A1 (en)	2018-05-10
EP3362119B1 (de)	2020-03-25
WO2017064285A1 (de)	2017-04-20
EP3362119A1 (de)	2018-08-22
US20180214055A1 (en)	2018-08-02
MX2018004596A (es)	2019-09-04
KR20180075550A (ko)	2018-07-04
ZA201802187B (en)	2020-10-28
CA3000908A1 (en)	2017-04-20
US10905813B2 (en)	2021-02-02
BR112018007521A2 (pt)	2018-10-23

Legal Events

Date	Code	Title	Description
2018-07-26	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180613
2019-10-10	A621	Written request for application examination	Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20191010
2020-01-16	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200116
2020-09-29	A977	Report on retrieval	Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200929
2020-10-13	A131	Notification of reasons for refusal	Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20201013
2021-01-12	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210112
2021-03-12	A601	Written request for extension of time	Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20210312
2021-04-08	A521	Request for written amendment filed	Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210408
2021-04-22	TRDD	Decision of grant or rejection written
2021-05-11	A01	Written decision to grant a patent or to grant a registration (utility model)	Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210511
2021-06-10	A61	First payment of annual fees (during grant procedure)	Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210608
2021-06-17	R150	Certificate of patent or registration of utility model	Ref document number: 6899590 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150
2024-06-17	LAPS	Cancellation because of no payment of annual fees

Publication	Publication Date	Title
US20210162109A1 (en)	2021-06-03	Membrane catheter
EP1930034B1 (en)	2012-11-14	An integrated centrifugal blood pump-oxygenator, an extracorporeal life support system and a method of de-bubbling and priming an extracorporeal life support system
JP6514109B2 (ja)	2019-05-15	血液透析濾過方法
JP4897811B2 (ja)	2012-03-14	液体中の物質を増大及び／又は減少させるための装置
Naruse et al.	2007	Artificial and bioartificial liver support: a review of perfusion treatment for hepatic failure patients
US10543052B2 (en)	2020-01-28	Portable dialysis cabinet
Elliott	2000	Hemodialysis
JP4177898B2 (ja)	2008-11-05	腹腔内圧を制御した連続式フロースルー腹膜透析（ｃｆｐｄ）法
ES2568916T5 (es)	2019-11-26	Sitio de infusión para mezcla de fluidos mejorada
JP2018535731A5 (2)	2020-02-27
UA128609C2 (uk)	2024-08-28	Модульний пристрій екстракорпорального життєзабезпечення, який носять, для мобільного лікування одиничної або поліорганної недостатності
Hoenich et al.	1989	Dialysers
US9950103B2 (en)	2018-04-24	Combination kidney and liver dialysis system and method
Runge et al.	1993	Hemodialysis: evidence of enhanced molecular clearance and ultrafiltration volume by using pulsatile flow
Zhang et al.	2012	A novel wearable pump-lung device: in vitro and acute in vivo study
JP2004049301A (ja)	2004-02-19	血液浄化装置
川人伸次 et al.	2002	Feasibility of a new hollow fiber silicone membrane oxygenator for long-term ECMO application
Raff	2021	Membrane Processes in Artificial Organs
Kim et al.	2010	Extracorporeal Blood-Filtering Technologies
Kirwan et al.	2009	The artificial kidney
Suresh et al.	2009	Principles of extracorporeal therapy: haemodialysis, haemofiltration and haemodiafiltration
Tetta et al.	2003	New perspectives in hemodialytic strategies
Aboras et al.	2005	Continuous convective renal replacement (CCRR) system: A new modality of wearable artificial kidney
JP2006325833A (ja)	2006-12-07	血中微粒子製剤の除去装置
Miyamoto et al.	2012	Early Dialysate Delivery Systems in Japan